跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRIFEME ethinylestradiol/levonorgestrel tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
TRIFEME ethinylestradiol/levonorgestrel tablet blister pack
Approved
STANDARD
TRIFEME ethinylestradiol/levonorgestrel tablet blister pack
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
79ceb7f08d9deabd
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
79ceb7f08d9deabd
Product Name
TRIFEME ethinylestradiol/levonorgestrel tablet blister pack
Artg Id
40133
Artg Name
TRIFEME ethinylestradiol/levonorgestrel tablet blister pack
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1992-06-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/51fd6e0260599e035eb6ecd9ef1d99f0.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4ce4ce6b37039ac3afb8bb29a4ab9c9f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
79ceb7f08d9deabd
Type
Standard
Back to TGA Approvals